Funding for this research was provided by:
National Natural Science Foundation of China Integration Project (91943301)
National Natural Science Foundation of China (81820108028)
Research Unit of Prospective Cohort of Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences (2019RU038)
Received: 25 January 2022
Accepted: 1 August 2022
First Online: 19 September 2022
: The UK Biobank study was approved by the National Research Ethics Service Committee North West-Haydock. And each participant gave their informed written consent. Resource data were obtained under Application Number 82535.
: Not applicable.
: The authors declare no competing interests.